South Africa’s Aspen Pharmacare is growing its global footprint with a new agreement, worth up to 92.6 million euros ($100.3 million), to buy Sandoz’s China operations.
Novo Nordisk, following a similar move by its diabetes rival Eli Lilly, is teaming up with Aspen Pharmacare to shore up insulin supplies in Africa, which currently imports more than 80% of its medicine.
Aspen revenue exceeds R40 billion with accelerated medium-term growth anticipated
Aspen and Lilly enter into agreement in South Africa and the rest of Sub-Saharan Africa
Aspen, Saudi Chemical Company Holding and its subsidiary AJA Pharma enter into a memorandum of understanding.
Aspen hosts Mandela Day for 13th consecutive year, having reached 865 000 beneficiaries
Last year, South African-based vaccine manufacturer Aspen Pharmacare was facing reports that it had not received a single order for its manufactured Covid-19 shots and that manufacturing lines were sitting idle. But now the vaccine producer is looking to turn things around.
Aspen reports a creditable and resilient performance under challenging trading conditions
JOHANNESBURG, March 1 (Reuters) - South African drugmaker Aspen Pharmacare (APNJ.J) is close to signing four partnerships to revive its COVID-19 vaccine production lines that are generating no revenues, its CEO said, sending its shares up almost 10% in the day.
Aspen Pharma Group has announced that it will receive USD30 million from the Bill & Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations (CEPI)